The impact of opioid, cannabis and cocaine use disorder on the risk of diabetic retinopathy in patients with type 2 diabetes mellitus
Addiction · 2025
DOI: 10.1111/add.70275 ↗Kurz gefasst
Fachartikel in der Zeitschrift Addiction, 2025. Verfasst von Ming-Pei Yueh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Retinopathy, Cocaine-Related Disorders, Opioid-Related Disorders. Die Arbeit nennt 41 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background and aims Opioid use disorder (OUD), cannabis use disorder (CUD) and cocaine use disorder have been associated with a range of adverse health outcomes, including certain ocular manifestations; however, their impact on diabetic retinopathy (DR) remains insufficiently explored. This study aimed to measure the association between OUD, CUD and cocaine use disorder and the risk of DR among patients with type 2 diabetes mellitus (T2DM).
Design
Propensity‐score‐matched retrospective cohort study.
Setting
This study used the TriNetX US Collaborative Network to access electronic health records (EHRs), including data on demographics, diagnoses, medication use and laboratory results. Participants/cases A total of 131 088 adult patients with T2DM and comorbid OUD, CUD or cocaine use disorder, and 131 088 adult patients with T2DM without these conditions, were identified following propensity score matching.
Measurements
The primary outcome was the risk of DR evaluated over a 5‐year follow‐up period. The risks of various DR subtypes and diabetic macular edema (DME) were also assessed. Hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated.
Findings
Over a 5‐year follow‐up period, patients with T2DM comorbid with OUD, CUD or cocaine use disorder had a statistically significantly higher risk of developing DR [HR (95% CI) = 2.90 (2.55–3.30), P < 0.00] compared with those without any drug use disorder. Drug use disorders were also associated with elevated risks of vision‐threatening diabetic retinopathy (VTDR) [HR (95% CI) = 2.78 (2.24–3.46), P < 0.00], non‐proliferative diabetic retinopathy (NPDR) [HR (95% CI) = 3.10 (2.61–3.68), P < 0.00], proliferative diabetic retinopathy (PDR) [HR (95% CI) = 3.17 (2.26–4.45), P < 0.00] and DME [HR (95% CI) = 2.64 (2.04–3.42), P < 0.00] among patients with T2DM.
Conclusions
Opioid use disorder, cannabis use disorder and cocaine use disorder appear to be associated with an elevated risk of diabetic retinopathy among patients with type 2 diabetes mellitus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan.
- Division of Family Medicine, Department of Community Medicine, Landseed International Hospital, Taoyuan, Taiwan.
- Department of Ophthalmology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
- Department of Surgery, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
- Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.
- Department of General Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
ORCID-Profile: Ming-Pei Yueh, Cyuan-Yi Yeh, Shih-Kai Kao
Zitieren
APA
Yueh, M. P., Yu, Y. T., Yeh, C. Y., Cheng, K. W., & Kao, S. K. (2025). The impact of opioid, cannabis and cocaine use disorder on the risk of diabetic retinopathy in patients with type 2 diabetes mellitus. Addiction. https://doi.org/10.1111/add.70275
Vancouver
Yueh MP, Yu YT, Yeh CY, Cheng KW, Kao SK. The impact of opioid, cannabis and cocaine use disorder on the risk of diabetic retinopathy in patients with type 2 diabetes mellitus. Addiction. 2025. doi:10.1111/add.70275
BibTeX
@article{Yueh2025,
author = {Yueh, Ming-Pei and Yu, Yu-Ting and Yeh, Cyuan-Yi and Cheng, Kai-Wen and Kao, Shih-Kai},
title = {The impact of opioid, cannabis and cocaine use disorder on the risk of diabetic retinopathy in patients with type 2 diabetes mellitus},
journal = {Addiction},
year = {2025},
doi = {10.1111/add.70275}
}
EUVIMED